A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study

Peter C. Adamson, Brigitte C. Widemann, Robert F. Murphy, Andrea F. Gillespie, Frank M. Balis, Gregory H. Reaman, Nita L. Seibel

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences